Columbamine suppresses the proliferation and neovascularization of metastatic osteosarcoma U2OS cells with low cytotoxicity.

[1]  Ping Yang,et al.  Lycorine hydrochloride inhibits metastatic melanoma cell‐dominant vasculogenic mimicry , 2012, Pigment cell & melanoma research.

[2]  J. Radons,et al.  Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells. , 2012, International journal of oncology.

[3]  Lei Zhou,et al.  Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry , 2012, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[4]  Ruifang Liu,et al.  Novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt lymphoma Namalwa cells , 2012, Leukemia & lymphoma.

[5]  P. Houghton,et al.  Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12 , 2012, PloS one.

[6]  Quansheng Zhou,et al.  SZ-117, a monoclonal antibody against matrix metalloproteinase-2 inhibits tumor cell-mediated angiogenesis. , 2012, Hybridoma.

[7]  C. Khanna,et al.  A review of the association between osteosarcoma metastasis and protein translation. , 2012, Journal of comparative pathology.

[8]  Mei Wang,et al.  The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review , 2012, Journal of Cancer Research and Clinical Oncology.

[9]  Hai-wei Zhang,et al.  Gambogic acid inhibits tumor cell adhesion by suppressing integrin β1 and membrane lipid rafts-associated integrin signaling pathway. , 2011, Biochemical pharmacology.

[10]  Ke Chen,et al.  Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma , 2011, Medical oncology.

[11]  U. Dirksen,et al.  Risk of recurrence and survival after relapse in patients with Ewing sarcoma , 2011, Pediatric blood & cancer.

[12]  D. D’Adamo.  Appraising the current role of chemotherapy for the treatment of sarcoma. , 2011, Seminars in oncology.

[13]  Mauro Biffoni,et al.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.

[14]  N. Lu,et al.  Inhibitory effects of GL-V9 on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-2/9. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  C. Cox,et al.  Location of pulmonary metastasis in pediatric osteosarcoma is predictive of outcome. , 2011, Journal of pediatric surgery.

[16]  Baoan Ma,et al.  Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma. , 2011, Acta histochemica.

[17]  Shuhua Yang,et al.  Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro , 2011, BMC musculoskeletal disorders.

[18]  Ruiyun Zhang,et al.  IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer , 2011, Oncogene.

[19]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[20]  Peter F. M. Choong,et al.  The Molecular Pathogenesis of Osteosarcoma: A Review , 2011, Sarcoma.

[21]  M. Pennell,et al.  Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines , 2011, BMC Cancer.

[22]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[23]  Xu Ma,et al.  Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells. , 2010, Cancer letters.

[24]  Rong Wang,et al.  Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.

[25]  G. Bacci,et al.  High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005. , 2010, Surgical oncology.

[26]  V. Tjan-Heijnen,et al.  Signalling pathways in vasculogenic mimicry. , 2010, Biochimica et biophysica acta.

[27]  Huawu Zeng,et al.  Anti-inflammatory and anti-nociceptive activities of compounds from Tinospora sagittata (Oliv.) Gagnep. , 2010, Archives of pharmacal research.

[28]  Q. Wang,et al.  The Role of Matrix Metalloproteinase 2 on the Survival of Patients with Non-Small Cell Lung Cancer: A Systematic Review with Meta-Analysis , 2010, Cancer investigation.

[29]  Baocun Sun,et al.  Vasculogenic Mimicry: a New Prognostic Sign of Gastric Adenocarcinoma , 2010, Pathology & Oncology Research.

[30]  Li-zhi Zhang,et al.  The Role of VE-cadherin in Osteosarcoma Cells , 2010, Pathology & Oncology Research.

[31]  P. Pauwels,et al.  Prognostic Role of Vasculogenic Mimicry in Colorectal Cancer , 2009, Diseases of the colon and rectum.

[32]  L. Mirabello,et al.  Osteosarcoma incidence and survival rates from 1973 to 2004 , 2009, Cancer.

[33]  X. Jiao,et al.  Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia cells. , 2009, Cancer letters.

[34]  V. Kosma,et al.  Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer. , 2008, Histology and histopathology.

[35]  X. Cai,et al.  VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro. , 2008, Experimental oncology.

[36]  P. Schimmel,et al.  Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine. , 2008, Methods.

[37]  M. Hendrix,et al.  Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: Role of the Eph receptors , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[38]  Baocun Sun,et al.  Vasculogenic mimicry: current status and future prospects. , 2007, Cancer letters.

[39]  Tetsurou Matsumoto,et al.  Current and future status of prostate cancer chemoprevention , 2006, Expert review of anticancer therapy.

[40]  Olivier Delattre,et al.  Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. , 2005, Cancer research.

[41]  Wei Zhang,et al.  Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. , 2004, International journal of oncology.

[42]  Jia Yongwei,et al.  Vascular channel formation by osteosarcoma cells in vitro: Vasculogenic mimicry , 2003 .

[43]  M. Hendrix,et al.  Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: Role in vasculogenic mimicry , 2002, The Prostate.

[44]  T. Iwanaga,et al.  Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. , 2002, Cancer research.

[45]  M. Hendrix,et al.  Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). , 2001, Cancer research.

[46]  M. Hendrix,et al.  Molecular determinants of ovarian cancer plasticity. , 2001, The American journal of pathology.

[47]  P. F. Russell,et al.  In vitro antiplasmodial, antiamoebic, and cytotoxic activities of some monomeric isoquinoline alkaloids. , 2000, Journal of natural products.

[48]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[49]  V. Mišík,et al.  Lipoxygenase inhibition and antioxidant properties of protoberberine and aporphine alkaloids isolated from Mahonia aquifolium. , 1995, Planta medica.

[50]  Xuegang Li,et al.  Cytotoxicity and antihyperglycemic effect of minor constituents from Rhizoma Coptis in HepG2 cells. , 2012, Fitoterapia.

[51]  M. Kapoor,et al.  Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality , 2010, Nature Structural &Molecular Biology.

[52]  S. Ferrari,et al.  The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the Italian Rizzoli experience. Impact on the future. , 2009, Cancer treatment and research.

[53]  A. Mori,et al.  Tumour plasticity and extravascular circulation in ECV304 human bladder carcinoma cells. , 2006, Anticancer research.

[54]  J. Mei,et al.  Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry. , 2004, Chinese medical journal.